Diseases, Conditions, Syndromes

ICAAC: Moxifloxacin regimens are not noninferior for TB

(HealthDay)—For patients with uncomplicated, smear-positive pulmonary tuberculosis, moxifloxacin-containing regimens over four months are not noninferior to a control regimen, according to a study published online Sept. ...

Diseases, Conditions, Syndromes

Scientists: Novel TB drug combo passes first test

Scientists are hot on the trail of a new tuberculosis treatment that a small study suggests might one day offer an alternative to battle this deadly lung disease, even if it is resistant to today's two main drugs.

Medications

Administering antibiotics through the cornea

The anatomic and physiologic structure of the eyes constitutes an important barrier when administering medicine. The amount of medicine that passes through the cornea via creams or drops is very limited, and it is necessary ...

Oncology & Cancer

Moxifloxacin monotherapy equivalent to antibiotic combo

(HealthDay)—Oral monotherapy with moxifloxacin is as efficacious and safe as combination therapy with ciprofloxacin plus amoxicillin/clavulanic acid for treatment of fever in adult patients with cancer and neutropenia who ...

page 1 from 2